Dysarthria was a relevant clinical finding in 28% of the cohort, reaching a 75% frequency in MYORG mutation carriers (p = 0.04), who also had higher rates of ataxia (62.5%) compared to other sub-groups. The gene discussed is MYORG; the disease is Ataxia.